TY - JOUR
T1 - Pregnancy outcomes in correlation with placental histopathology in subsequent pregnancies complicated by fetal growth restriction
AU - Levy, Michal
AU - Kovo, Michal
AU - Schreiber, Letizia
AU - Kleiner, Ilia
AU - Grinstein, Ehud
AU - Koren, Liron
AU - Barda, Giulia
AU - Bar, Jacob
AU - Weiner, Eran
N1 - Publisher Copyright:
© 2019
PY - 2019/5
Y1 - 2019/5
N2 - Objective: In attempt to shed new light on the etiopathogenesis of fetal growth restriction (FGR) we aimed to compare pregnancy outcomes and placental histopathology in cases of first vs. subsequent FGR occurrence. Study design: Pregnancy and placental reports of FGR pregnancies (defined by birth weight <10th percentile), born between 2008 and 2018 were reviewed. Included only cases with recurrent FGR, in two consecutive pregnancies, thus each subject served as her own control in two FGRs consecutive pregnancies. Neonatal outcome and placental histopathology were compared between the first FGR delivery (first FGR group) and the subsequent FGR delivery (subsequent FGR group). Composite adverse neonatal outcome was defined as one or more early neonatal complications. Results: Included in the study a total of 96 cases with recurrence of FGR pregnancies. Placentas from the first FGR group were characterized by higher rate of maternal vascular malperfusion (MVM) lesions as compared with the subsequent FGR group (71.8% versus 55.2%, respectively, p = 0 .02). Adverse neonatal outcome was more prevalent in the first FGR group as compared to the recurrent FGR group (41.6% versus 25%, respectively, p = 0.02). After controlling for confounders, using multivariate regression analysis, placental MVM lesions (aOR = 1.36, 95% CI = 1.12–1.45) and composite adverse neonatal outcome (aOR = 1.18 95% CI = 1.09–1.55) were found to be independently associated with the first FGR group. Conclusion: First event of FGR is associated with a higher rate of placental MVM lesions and adverse neonatal outcome as compared to FGR in subsequent pregnancies.
AB - Objective: In attempt to shed new light on the etiopathogenesis of fetal growth restriction (FGR) we aimed to compare pregnancy outcomes and placental histopathology in cases of first vs. subsequent FGR occurrence. Study design: Pregnancy and placental reports of FGR pregnancies (defined by birth weight <10th percentile), born between 2008 and 2018 were reviewed. Included only cases with recurrent FGR, in two consecutive pregnancies, thus each subject served as her own control in two FGRs consecutive pregnancies. Neonatal outcome and placental histopathology were compared between the first FGR delivery (first FGR group) and the subsequent FGR delivery (subsequent FGR group). Composite adverse neonatal outcome was defined as one or more early neonatal complications. Results: Included in the study a total of 96 cases with recurrence of FGR pregnancies. Placentas from the first FGR group were characterized by higher rate of maternal vascular malperfusion (MVM) lesions as compared with the subsequent FGR group (71.8% versus 55.2%, respectively, p = 0 .02). Adverse neonatal outcome was more prevalent in the first FGR group as compared to the recurrent FGR group (41.6% versus 25%, respectively, p = 0.02). After controlling for confounders, using multivariate regression analysis, placental MVM lesions (aOR = 1.36, 95% CI = 1.12–1.45) and composite adverse neonatal outcome (aOR = 1.18 95% CI = 1.09–1.55) were found to be independently associated with the first FGR group. Conclusion: First event of FGR is associated with a higher rate of placental MVM lesions and adverse neonatal outcome as compared to FGR in subsequent pregnancies.
KW - Fetal growth restriction
KW - Maternal malperfusion lesions
KW - Neonatal outcome
KW - Placental pathology
UR - http://www.scopus.com/inward/record.url?scp=85063763486&partnerID=8YFLogxK
U2 - 10.1016/j.placenta.2019.04.001
DO - 10.1016/j.placenta.2019.04.001
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 31103064
AN - SCOPUS:85063763486
SN - 0143-4004
VL - 80
SP - 36
EP - 41
JO - Placenta
JF - Placenta
ER -